<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="142956">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01952184</url>
  </required_header>
  <id_info>
    <org_study_id>2013/777</org_study_id>
    <nct_id>NCT01952184</nct_id>
  </id_info>
  <brief_title>Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage.</brief_title>
  <official_title>Oocyte Survival After Vitrification in an Open or Closed Commercial Device: Study on Sibling Donor Oocytes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <authority>Belgium: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Donor sibling oocytes will be vitrified with two commercialy available devices. The first
      device is closed vitrification with closed storage and the second device is open
      vitrification with closed storage. Oocyte acceptors receive oocytes from both devices. With
      the increase in cooling rate generated by the open vitrification (second device), we expect
      to get an increase in survival rate of 10%.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Survival rate</measure>
    <time_frame>up to 6 days after every warming cycle</time_frame>
    <safety_issue>No</safety_issue>
    <description>The purpose is to assess the survival rate of donor oocytes with the two vitrification devices.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Embryo development</measure>
    <time_frame>up to 6 days after every warming cycle</time_frame>
    <safety_issue>No</safety_issue>
    <description>The purpose is to analyse the pre-implantation development of donor oocytes vitrified with two different devices.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Survival</condition>
  <arm_group>
    <arm_group_label>closed vitrification with closed storage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Half of the oocytes of every donor will be vitrified with the Cryo Bio Systems High Security vitrification (CBSvit HS) device; the standard device in our lab.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>open vitrification with closed storage</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Half of the oocytes of every donor will be vitrified with the Cryotop closed system (Cryotop SC).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CBSvit HS device</intervention_name>
    <arm_group_label>closed vitrification with closed storage</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cryotop SC device</intervention_name>
    <arm_group_label>open vitrification with closed storage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Donor: ≤36 years old on day of oocyte retrieval

          -  Donor: ≥ 6 mature oocytes

        Exclusion Criteria:

          -  Donor: &lt; 6 mature oocytes
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neelke De Munck, MSc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centrum voor Reproductieve Geneeskunde, UZBrussel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Neelke De Munck, MSc.</last_name>
    <phone>024776694</phone>
    <phone_ext>0032</phone_ext>
    <email>neelke.demunck@uzbrussel.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Brussel</name>
      <address>
        <city>Jette</city>
        <state>Brussels</state>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neelke De Munck, MSc.</last_name>
      <phone>024776694</phone>
      <phone_ext>0032</phone_ext>
      <email>neelke.demunck@uzbrussel.be</email>
    </contact>
    <investigator>
      <last_name>Neelke De Munck, MSc.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 27, 2013</lastchanged_date>
  <firstreceived_date>September 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitair Ziekenhuis Brussel</investigator_affiliation>
    <investigator_full_name>Neelke De Munck</investigator_full_name>
    <investigator_title>MSc.</investigator_title>
  </responsible_party>
  <keyword>vitrification</keyword>
  <keyword>oocyte</keyword>
  <keyword>donor</keyword>
  <keyword>open</keyword>
  <keyword>closed</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
